何亚琼说，在产品创新方面，工信部将致力于加快建设"用户需求—智能设计—柔性生产—精准服务"全 产业链的数字化体系。例如在家电行业，支持发展基于用户行为数据感知、分析和决策的智能家电生态 系统。以智能冰箱为例，它可以自动识别食材消耗情况，生成购物清单并提醒用户。 在场景拓展方面，工信部将积极推动人工智能技术在更多消费场景的融合渗透，创造新的体验，激发新 的需求。在"人工智能＋智能家居"场景中，推动智能单品向全屋智能联动发展，构建沉浸式、主动式、 互联互通的智能生活体验。 此外，在"人工智能＋健康养老"场景方面，工信部将实施"人工智能+老年用品"行动，发展康复辅具、 健康监测产品、人形机器人等"AI智能体"，目标是实现从"机械照护"到"温情陪伴"的转变。(完) 来源：中国新闻网 中国工信部：推动人工智能技术在消费品领域加快落地 编辑：陈俊明 中新社北京11月27日电 (记者 刘育英)在中国国务院新闻办公室27日举行的国务院政策例行吹风会上， 中国工业和信息化部消费品工业司司长何亚琼表示，人工智能成为促进消费的"催化剂"。工信部将在产 品创新和场景创新两个方面发力，推动人工智能技术在消费品领域加快落地。 何亚琼介绍 ...

11月27日上午10点，国新办举行国务院政策例行吹风会，介绍增强消费品供需适配性进一步促进消费政策措施有关情况。记者从会上获悉，截至今年上半 年，我国生成式人工智能产品用户规模已经达到了5.15亿，应用场景持续拓展，人工智能终端新产品竞相涌现。 在场景拓展方面，将积极推动人工智能技术在更多消费场景的融合渗透，创造新的体验，激发新的需求。比如，在"人工智能＋智能家居"场景方面，将推动 智能单品向全屋智能联动发展，构建沉浸式、主动式、互联互通的智能生活体验。像现在比较火的人工智能眼镜，能用第一视角拍摄，解放了双手，并且可 以随时响应我们的口令，形成服务的入口，及时把导航等信息投射到镜片上，而且AI还会记住我们的习惯和喜好，让服务更加个性化，更加符合每个人的 日常需求。再比如，我们在拓展"人工智能＋健康养老"场景方面，实施"人工智能+老年用品"行动，发展康复辅具、健康监测产品、人形机器人等"AI智能 体"，实现从"机械照护"到"温情陪伴"的转变。 下一步，工信部将坚持需求牵引、技术驱动、生态协同，全力推动人工智能等新一代信息技术与消费品领域深度融合，不断拓展新的消费场景。 来源：北京日报客户端 记者：吴娜 工业和信 ...

"总体来看，我国消费品供给已进入优质优价新发展阶段，基本满足了人民美好生活需要。但部分领域 供需结构性错配问题依然存在，如部分产品供给过剩和优质供给不足并存，国内首饰、箱包、化妆品等 领域的高端品牌还比较少；新旧动能转换仍然在路上，适应居民品质化、个性化需求的新产品创新应用 和供给不足；部分消费热点尚未完全充分供给，养老育幼、文旅和智能消费等需求旺盛，老年用品、智 能终端、低空观光、IP衍生品等个性化供给数量和质量尚不能满足需求。" 工业和信息化部副部长谢远 生说。 近日，经国务院同意，工业和信息化部会同五部门联合印发了《关于增强消费品供需适配性进一步促进 消费的实施方案》（简称《实施方案》）。其中提出加大生成式人工智能、3D数字化设计等新工具应 用，开发人工智能终端产品，提供娱乐、健康、陪护等生活服务。 "截至今年上半年，我国生成式人工智能产品用户规模已经达到了5.15亿，应用场景持续拓展，人工智 能终端新产品竞相涌现。" 何亚琼介绍，工信部将在产品创新和场景创新两个方面发力，推动人工智能 技术在消费品领域加快落地。 "人工智能绝不仅仅是技术的惊艳，更需要我们通过对用户的洞察、市场的把握、商业模式的构建，形 ...

扬子晚报网讯（记者 朱亚运）11月24日上午，2025健康中国建设大会暨长三角智慧康养嘉年华活动在 南通开幕。本次活动以"数智创新服务银发，融汇共创健康中国"为主题，既搭建高端学术研讨的专业平 台，又打造了贴近民生的健康体验场景，推动数智技术和大健康老龄健康领域的深度融合，将为健康中 国建设注入强劲的长三角动能。 开幕式上，国家及省市相关部委领导、两院院士、国内大型三甲医院院长专家、知名企业负责人等各界 代表参加。南通市人民政府与健康报社战略合作协议签，崇川区人民政府、南通市民政局、南通市医保 局与通用技术康养公司战略合作协议的签约仪式；一批生物医药项目集中签约。随后，各路专家学者将 集中展现健康科技领域的前沿创新成果。 南通，作为著名的"长寿之乡"和长三角北翼的经济重镇，不仅在经济发展上活力迸发，更在康养事业领 域有着深厚的底蕴与积极的探索。 与此同时，南通康养产业基础实、潜力大。德国默克、拜耳、瑞士斯福瑞等国际知名企业长期深耕，澳 斯康、精华制药（002349）等本土领军企业培育壮大，北大生命科学华东产研院、复旦张江医学研究院 等科创平台加快布局，启东开发区、海门临江新区、市北高新（600604）区、紫琅 ...

近日，2025天津国际银发经济博览会（以下简称银博会）在国家会展中心（天津）举行，静海区多家企 业积极参展。其中，天津子牙经济技术开发区高新产业园（以下简称高新产业园）携7家核心企业集中 亮相，并成功签约2单重点项目，助力银发经济发展。 走进展会的高新产业园银发经济展区，康复辅 具、医养健康产品、医疗器械等各类适老产品琳琅满目，吸引不少市民前来体验，详细询问产品功能与 使用方法。作为此次展会的"重头戏"，高新产业园签约强脉冲光干眼治疗仪规模化生产、医工融合创新 转化平台两大重点项目，不仅为区域银发经济高质量发展注入新动能，更按下了国家级银发经济产业园 建设的"加速键"。（天津日报） ...

天眼查App显示，近日，上海宝镜岛眼镜有限公司成立，法定代表人为黄海，注册资本10万人民币，经 营范围为一般项目：眼镜销售（不含隐形眼镜）；制镜及类似品加工；光学仪器销售；光学玻璃销售； 康复辅具适配服务。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）许可项目：第三 类医疗器械经营。（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关 部门批准文件或许可证件为准）。 ...

Core Viewpoint - The "2025 Haizhou District Silver Age Life Carnival" successfully concluded on November 2, aiming to create a comprehensive elderly care service platform that integrates product experience, service consultation, and cultural entertainment, receiving widespread acclaim from participants [1][3]. Group 1: Event Overview - The event featured four major exhibition areas: elderly care services, age-friendly renovation products, elderly finance, and elderly culture and tourism, addressing the daily needs of senior citizens [3]. - The elderly care services area showcased various service models, including community and institutional care, while the age-friendly renovation products area offered trials of smart health monitoring devices and rehabilitation aids [3]. - The elderly finance area provided personalized retirement financial planning consultations, and the culture and tourism area introduced cultural courses and age-appropriate travel routes [3]. Group 2: Community Engagement - The event maintained a public welfare attribute by offering free health checks, legal consultations, and financial advice, alongside cultural activities such as talent shows and live teaching, highlighting the positive spirit of modern seniors [3][5]. - Participant feedback indicated that the event was both practical and enjoyable, reflecting the community's care for the elderly [5]. Group 3: Strategic Implications - The Haizhou District Civil Affairs Bureau described the event as a beneficial attempt to integrate government, enterprise, and social resources to enhance the elderly care service system, aiming to improve the quality of life for seniors and foster a respectful social atmosphere [5][6]. - The successful hosting of the carnival established a platform for connecting social resources with elderly care needs, marking a successful exploration of a new model for elderly care characterized by "government guidance, social participation, and market operation" [6].

Core Viewpoint - The company, Kefo Medical, is actively investing in the brain-computer interface sector, indicating a strategic shift towards integrating smart medical solutions and neurotechnology [1] Group 1: Strategic Investments - The company announced a strategic investment in Newlink Medical, focusing on implantable brain-computer interface technology, particularly in developing bionic eye and ear products [1] - This investment aligns with the company's existing hearing business, especially in addressing congenital hearing loss [1] - The company has also recently invested in Lizi Intelligent, which is dedicated to the research and development of brain-machine intelligence and robotic embodiment technology [1] Group 2: Future Growth and Synergy - The investments are expected to create strategic synergies with the company's rehabilitation assistive products, expanding intelligent rehabilitation solutions [1] - By positioning itself in cutting-edge fields like brain-computer interfaces, the company aims to explore the integration of smart medical solutions and neurotechnology [1] - This forward-looking strategy is intended to enhance the company's technological advantages and growth potential in hearing rehabilitation, smart assistive devices, and precision health management [1]

Core Points - A new company named Fengcheng Yuzhang Optical Co., Ltd. has been established with a registered capital of 50,000 RMB [1] - The legal representative of the company is Wang Shuting [1] Business Scope - The company is authorized to operate in the following areas: - Third-class medical device sales - Food sales (subject to approval by relevant authorities) [1] - General business activities include: - Second-class medical device sales - Sales of eyeglasses (excluding contact lenses) - Sales of optical glass - Rehabilitation aid fitting services - Sales of health food (pre-packaged) - Sales of food (only pre-packaged food) - Sales of office supplies - Sales of daily necessities (excluding projects requiring approval) [1]

Core Insights - The company reported a revenue of 902 million yuan for Q3 2025, representing a year-on-year growth of 30.72% [1] - The net profit attributable to shareholders reached 92.83 million yuan, with a year-on-year increase of 38.68% [1] Company Overview - The company has been a leading player in the home medical device industry for nearly two decades, establishing a comprehensive industrial chain in R&D, production, sales, and services [1] - Since its listing on the ChiNext board in 2021, the company has accelerated its transformation from a channel-driven model to a R&D-driven approach [1] R&D and Innovation - As of June 30, 2025, the company holds a total of 676 patents, which is four times the number at the time of its IPO [1] - The company has established three research institutes and has a R&D team of nearly 400 people, leading to a significant increase in innovative outcomes [1] Manufacturing Capabilities - The company's production bases in Changsha and Xiangyin have been fully constructed and operational, creating a modern intelligent manufacturing system covering multiple product categories [1] - Automation and digital upgrades have significantly improved production efficiency and product consistency [1] International Expansion - The company's overseas business revenue grew by over 200% year-on-year in the first half of 2025, with products now available in over 60 countries and regions globally [1] - Recent acquisitions of Shanghai Huazhou and Hong Kong Ximan have further expanded the company's market presence [1] Strategic Transformation - The company has successfully transitioned from a traditional agency model to a comprehensive medical device enterprise that integrates R&D innovation, intelligent manufacturing, and omnichannel marketing [1] - Future growth is expected to be driven by the continued expansion of core product categories, deepening of proprietary brands, and internationalization strategies [1]